Literature DB >> 33348845

Phosphate Groups in the Lipid A Moiety Determine the Effects of LPS on Hepatic Stellate Cells: A Role for LPS-Dephosphorylating Activity in Liver Fibrosis.

Marlies Schippers1, Eduard Post1, Ilse Eichhorn1, Jitske Langeland1, Leonie Beljaars1, Madhu S Malo2,3, Richard A Hodin2, José Luis Millán4, Yury Popov5, Detlef Schuppan5,6, Klaas Poelstra1.   

Abstract

Alkaline phosphatase (AP) activity is highly upregulated in plasma during liver diseases. Previously, we demonstrated that AP is able to detoxify lipopolysaccharide (LPS) by dephosphorylating its lipid A moiety. Because a role of gut-derived LPS in liver fibrogenesis has become evident, we now examined the relevance of phosphate groups in the lipid A moiety in this process. The effects of mono-phosphoryl and di-phosphoryl lipid A (MPLA and DPLA, respectively) were studied in vitro and LPS-dephosphorylating activity was studied in normal and fibrotic mouse and human livers. The effects of intestinal AP were studied in mice with CCL4-induced liver fibrosis. DPLA strongly stimulated fibrogenic and inflammatory activities in primary rat hepatic stellate cells (rHSCs) and RAW264.7 macrophages with similar potency as full length LPS. However, MPLA did not affect any of the parameters. LPS-dephosphorylating activity was found in mouse and human livers and was strongly increased during fibrogenesis. Treatment of fibrotic mice with intravenous intestinal-AP significantly attenuated intrahepatic desmin+- and αSMA+ -HSC and CD68+- macrophage accumulation. In conclusion, the lack of biological activity of MPLA, contrasting with the profound activities of DPLA, shows the relevance of LPS-dephosphorylating activity. The upregulation of LPS-dephosphorylating activity in fibrotic livers and the protective effects of exogenous AP during fibrogenesis indicate an important physiological role of intestinal-derived AP during liver fibrosis.

Entities:  

Keywords:  alkaline phosphatase; hepatic stellate cells; lipid A; lipopolysaccharide; liver fibrosis

Mesh:

Substances:

Year:  2020        PMID: 33348845      PMCID: PMC7766276          DOI: 10.3390/cells9122708

Source DB:  PubMed          Journal:  Cells        ISSN: 2073-4409            Impact factor:   6.600


  55 in total

1.  Hyperresponsivity to low-dose endotoxin during progression to nonalcoholic steatohepatitis is regulated by leptin-mediated signaling.

Authors:  Kento Imajo; Koji Fujita; Masato Yoneda; Yuichi Nozaki; Yuji Ogawa; Yoshiyasu Shinohara; Shingo Kato; Hironori Mawatari; Wataru Shibata; Hiroshi Kitani; Kenichi Ikejima; Hiroyuki Kirikoshi; Noriko Nakajima; Satoru Saito; Shiro Maeyama; Sumio Watanabe; Koichiro Wada; Atsushi Nakajima
Journal:  Cell Metab       Date:  2012-07-03       Impact factor: 27.287

2.  Intestinal Alkaline Phosphatase Attenuates Alcohol-Induced Hepatosteatosis in Mice.

Authors:  Sulaiman R Hamarneh; Byeong-Moo Kim; Kanakaraju Kaliannan; Sara A Morrison; Tyler J Tantillo; Qingsong Tao; Mussa M Rafat Mohamed; Juan M Ramirez; Aaron Karas; Wei Liu; Dong Hu; Abeba Teshager; Sarah Shireen Gul; Konstantinos P Economopoulos; Atul K Bhan; Madhu S Malo; Michael Y Choi; Richard A Hodin
Journal:  Dig Dis Sci       Date:  2017-04-19       Impact factor: 3.199

3.  Intestinal alkaline phosphatase preserves the normal homeostasis of gut microbiota.

Authors:  M S Malo; S Nasrin Alam; G Mostafa; S J Zeller; P V Johnson; N Mohammad; K T Chen; A K Moss; S Ramasamy; A Faruqui; S Hodin; P S Malo; F Ebrahimi; B Biswas; S Narisawa; J L Millán; H S Warren; J B Kaplan; C L Kitts; E L Hohmann; R A Hodin
Journal:  Gut       Date:  2010-11       Impact factor: 23.059

4.  Lipopolysaccharide induces the differentiation of hepatic progenitor cells into myofibroblasts via activation of the Hedgehog signaling pathway.

Authors:  Xiao-Rong Pan; Ying-Ying Jing; Wen-Ting Liu; Zhi-Peng Han; Rong Li; Yang Yang; Jing-Ni Zhu; Xiao-Yong Li; Pei-Pei Li; Li-Xin Wei
Journal:  Cell Cycle       Date:  2017-05-31       Impact factor: 4.534

5.  Protection against an Escherichia coli-induced sepsis by alkaline phosphatase in mice.

Authors:  Willem Ronald Verweij; Hafida Bentala; Ali Huizinga-van der Vlag; Anne Miek van Loenen-Weemaes; Kor Kooi; Dirk Klaas Fokke Meijer; Klaas Poelstra
Journal:  Shock       Date:  2004-08       Impact factor: 3.454

6.  Effect of Human Recombinant Alkaline Phosphatase on 7-Day Creatinine Clearance in Patients With Sepsis-Associated Acute Kidney Injury: A Randomized Clinical Trial.

Authors:  Peter Pickkers; Ravindra L Mehta; Patrick T Murray; Michael Joannidis; Bruce A Molitoris; John A Kellum; Mirjam Bachler; Eric A J Hoste; Oscar Hoiting; Kenneth Krell; Marlies Ostermann; Wim Rozendaal; Miia Valkonen; David Brealey; Albertus Beishuizen; Ferhat Meziani; Raghavan Murugan; Hilde de Geus; Didier Payen; Erik van den Berg; Jacques Arend
Journal:  JAMA       Date:  2018-11-20       Impact factor: 56.272

7.  Intestinal alkaline phosphatase prevents metabolic syndrome in mice.

Authors:  Kanakaraju Kaliannan; Sulaiman R Hamarneh; Konstantinos P Economopoulos; Sayeda Nasrin Alam; Omeed Moaven; Palak Patel; Nondita S Malo; Madhury Ray; Seyed M Abtahi; Nur Muhammad; Atri Raychowdhury; Abeba Teshager; Mussa M Rafat Mohamed; Angela K Moss; Rizwan Ahmed; Shahrad Hakimian; Sonoko Narisawa; José Luis Millán; Elizabeth Hohmann; H Shaw Warren; Atul K Bhan; Madhu S Malo; Richard A Hodin
Journal:  Proc Natl Acad Sci U S A       Date:  2013-04-08       Impact factor: 11.205

8.  Lipopolysaccharide Reverses Hepatic Stellate Cell Activation Through Modulation of cMyb, Small Mothers Against Decapentaplegic, and CCAAT/Enhancer-Binding Protein C/EBP Transcription Factors.

Authors:  Akanksha Sharma; Alok K Verma; Matthew Kofron; Ramesh Kudira; Alexander Miethke; Tong Wu; Jiang Wang; Chandrashekhar R Gandhi
Journal:  Hepatology       Date:  2020-10-22       Impact factor: 17.298

9.  Study protocol for a multicentre randomised controlled trial: Safety, Tolerability, efficacy and quality of life Of a human recombinant alkaline Phosphatase in patients with sepsis-associated Acute Kidney Injury (STOP-AKI).

Authors:  Esther Peters; Ravindra L Mehta; Patrick T Murray; Jürgen Hummel; Michael Joannidis; John A Kellum; Jacques Arend; Peter Pickkers
Journal:  BMJ Open       Date:  2016-09-27       Impact factor: 2.692

Review 10.  Innovative Drugs to Target Renal Inflammation in Sepsis: Alkaline Phosphatase.

Authors:  Femke Hümmeke-Oppers; Pleun Hemelaar; Peter Pickkers
Journal:  Front Pharmacol       Date:  2019-08-23       Impact factor: 5.810

View more
  2 in total

1.  Rifaximin Improves Spatial Learning and Memory Impairment in Rats with Liver Damage-Associated Neuroinflammation.

Authors:  Paola Leone; Gergana Mincheva; Tiziano Balzano; Michele Malaguarnera; Vicente Felipo; Marta Llansola
Journal:  Biomedicines       Date:  2022-05-28

2.  Special Issue on "Cellular and Molecular Mechanisms Underlying the Pathogenesis of Hepatic Fibrosis II".

Authors:  Ralf Weiskirchen
Journal:  Cells       Date:  2022-08-04       Impact factor: 7.666

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.